Company attributes
B2X
Founder
Pitchbook URL
Legal Name
Xenetic Biosciences, Inc.0
Number of Employees (Ranges)
1 – 10
Email Address
bd@xeneticbio.com0
info@xeneticbio.com0
xbio@jtcir.com0
Phone Number
+178177877200
+183347582470
Number of Employees
4
Full Address
40 Speen Street Suite 102 Framingham, MA 017010
CIK Number
Place of Incorporation
Investors
IRS Number
452,952,9620
Founded Date
2014
Total Funding Amount (USD)
23,366,250
Latest Funding Round Date
May 3, 2022
Competitors
Business Model
Commerce
Licensing
Stock Symbol
XBIO0
Exchange
Board of Directors
Latest Funding Type
NAICS Code
325,4110
Patents Assigned (Count)
1
Country
Headquarters
Other attributes
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
866,250
Market Capitalization
10,670,000
Previous Name
General Sales & Leasing, Inc.0
GENERAL AIRCRAFT INC.0
SIC Code
2,8340
Ticker Symbol
XBIO0
Wikidata ID
Xenetic Biosciences is a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
